Team:Caltech
From 2008.igem.org
(Difference between revisions)
Line 1: | Line 1: | ||
<div id="mainpage"> | <div id="mainpage"> | ||
- | <hr width=" | + | <hr width="900px"> |
<div id="about"> | <div id="about"> | ||
{{Caltech_iGEM_08}} | {{Caltech_iGEM_08}} | ||
</div> | </div> | ||
- | <hr width=" | + | <hr width="900px"> |
__NOTOC__ | __NOTOC__ | ||
- | {|cellspacing="5" cellpadding="10" style="background:#ffffff; width: | + | {|cellspacing="5" cellpadding="10" style="background:#ffffff; width: 900px;" |
|-valign="top" | |-valign="top" | ||
|style="background:#ffffff"| | |style="background:#ffffff"| |
Revision as of 18:13, 28 August 2008
People
|
{{{Content}}} |
</div>
The big ideaWe aim to engineer a probiotic bacterium to improve its medical applications. Our work focuses on four main areas: (1) pathogen defense, either by expression of pathogen-specific bacteriophage or by targeted bursts of reactive oxygen species; (2) vitamin over-expression and delivery; (3) treatment of lactose intolerance, by preferentially metabolizing lactose and funneling it to vitamin production; and (4) regulation of these three treatment functions to produce subpopulations specialized for each function. Why engineer gut microbes?The large intestine: an ideal bioreactorTalk about the colon Probiotic bacteria and other natural examplesTalk about probiotics Nissle 1917: Probiotic, commercially available E. coliTalk about Nissle 1917 For more details, please see our project page. |